CCL2 and neoplasm: During tumor development and progression, circulating bone marrow-derived monocytes are recruited to the tumor by chemokine C-C motif ligand 2 (CCL2) and macrophage colony stimulating factor (M-CSF)-1 where they differentiate into TAMs with a M2-like phenotype (65).